Prediction of human immunodeficiency virus type 1 drug resistance: Representation of target sequence mutational patterns via an n-grams approach
暂无分享,去创建一个
[1] Giorgio Palù,et al. Comparative evaluation of three computerized algorithms for prediction of antiretroviral susceptibility from HIV type 1 genotype. , 2004, The Journal of antimicrobial chemotherapy.
[2] R. Shafer,et al. Genotypic predictors of human immunodeficiency virus type 1 drug resistance , 2006, Proceedings of the National Academy of Sciences.
[3] Thomas Lengauer,et al. Predicting Response to Antiretroviral Treatment by Machine Learning: The EuResist Project , 2012, Intervirology.
[4] Amalio Telenti,et al. Update of the Drug Resistance Mutations in HIV-1: 2005. , 2005, Topics in HIV medicine : a publication of the International AIDS Society, USA.
[5] F. Heinz,et al. Comparison of virtual phenotype and HIV‐SEQ program (Stanford) interpretation for predicting drug resistance of HIV strains , 2002, HIV medicine.
[6] Judith Klein-Seetharaman,et al. PROTEINS: Structure, Function, and Bioinformatics 58:955–970 (2005) Protein Classification Based on Text Document Classification Techniques , 2022 .
[7] Leo Breiman,et al. Bagging Predictors , 1996, Machine Learning.
[8] S. Katebi,et al. Protein Superfamily Classification Using Fuzzy Rule-Based Classifier , 2009, IEEE Transactions on NanoBioscience.
[9] S. Broder,et al. The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic. , 2010, Antiviral research.
[10] Rolf Kaiser,et al. Correction: Antiretroviral Therapy Optimisation without Genotype Resistance Testing: A Perspective on Treatment History Based Models , 2011, PLoS ONE.
[11] Lynne Peeples,et al. Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy. , 2009, The New England journal of medicine.
[12] B. Larder,et al. Enhanced prediction of lopinavir resistance from genotype by use of artificial neural networks. , 2003, The Journal of infectious diseases.
[13] S. Mallal,et al. High sensitivity of human leukocyte antigen-b*5701 as a marker for immunologically confirmed abacavir hypersensitivity in white and black patients. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] Stephen E. Fienberg,et al. Discrete Multivariate Analysis: Theory and Practice , 1976 .
[15] B. Gazzard,et al. Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study , 2004, The Lancet.
[16] Ian H. Witten,et al. Data mining in bioinformatics using Weka , 2004, Bioinform..
[17] Yao Ju,et al. HLA-B~*5701 screening for hypersensitivity to abacavir , 2011 .
[18] Brendan Larder,et al. Non‐parametric methods to predict HIV drug susceptibility phenotype from genotype , 2003, Statistics in medicine.
[19] R. Samudrala,et al. Simple Linear Model Provides Highly Accurate Genotypic Predictions of HIV-1 Drug Resistance , 2003, Antiviral therapy.
[20] D. Richman,et al. Update of the drug resistance mutations in HIV-1: December 2010. , 2010, Topics in HIV medicine : a publication of the International AIDS Society, USA.
[21] Sorin Draghici,et al. Predicting HIV drug resistance with neural networks , 2003, Bioinform..
[22] Thomas Lengauer,et al. Geno2pheno: estimating phenotypic drug resistance from HIV-1 genotypes , 2003, Nucleic Acids Res..
[23] Leo Breiman,et al. Random Forests , 2001, Machine Learning.
[24] M Damashek,et al. Gauging Similarity with n-Grams: Language-Independent Categorization of Text , 1995, Science.
[25] Cathy H. Wu,et al. Motif identification neural design for rapid and sensitive protein family search , 1996, Comput. Appl. Biosci..
[26] Ivet Bahar,et al. The relationship between N‐gram patterns and protein secondary structure , 2007, Proteins.
[27] Kelvin Xi Zhang,et al. GAIA: a gram-based interaction analysis tool – an approach for identifying interacting domains in yeast , 2009, BMC Bioinformatics.
[28] Shuigeng Zhou,et al. Gene ontology-based protein function prediction by using sequence composition information. , 2010, Protein and peptide letters.
[29] O. Kirk,et al. Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration , 2008, The Lancet.
[30] Tommy F. Liu,et al. HIV-1 Protease and reverse-transcriptase mutations: correlations with antiretroviral therapy in subtype B isolates and implications for drug-resistance surveillance. , 2005, The Journal of infectious diseases.
[31] O. Kirk,et al. Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study. , 2010, The Journal of infectious diseases.